ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

BTAI BioXcel Therapeutics Inc

2.57
0.01 (0.39%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
BioXcel Therapeutics Inc BTAI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01 0.39% 2.57 09:00:00
개장가 저가 고가 종가 전일 종가
2.60 2.56 2.6701 2.57 2.56
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00GLOBEBioXcel Therapeutics to Report First Quarter 2024 Financial..
24/04/202423:30GLOBEBioXcel Therapeutics Announces Late-Breaking Abstract on..
22/04/202420:00GLOBEBioXcel Therapeutics Announces Plan for Evaluating BXCL501..
10/04/202420:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
25/03/202420:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
15/03/202420:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
12/03/202420:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
01/03/202421:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
14/02/202421:00EDGAR2Form 8-K - Current report
13/02/202423:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
13/02/202402:45EDGAR2Form 8-K - Current report
12/02/202421:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
09/02/202407:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/02/202406:53EDGAR2Form 8-K - Current report
09/02/202406:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
08/02/202421:08EDGAR2Form 8-K - Current report
06/02/202421:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
05/02/202421:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
23/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
13/01/202406:16EDGAR2Form S-3 - Registration statement under Securities Act of..
19/12/202306:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202321:22EDGAR2Form 8-K - Current report
12/12/202321:00EDGAR2Form 8-K - Current report
12/12/202321:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
11/12/202321:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
06/12/202321:00EDGAR2Form 8-K - Current report
30/11/202321:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
14/11/202301:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
14/11/202300:23EDGAR2Form RW - Registration Withdrawal Request
08/11/202321:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
06/11/202321:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
02/11/202319:01EDGAR2Form S-3 - Registration statement under Securities Act of..
31/10/202320:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
30/10/202320:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
25/10/202323:30APSStrong Open For Biotech Shares Following Phase 3 Comments
25/10/202320:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
20/10/202305:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/10/202320:06EDGAR2Form 8-K - Current report
10/10/202320:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
04/10/202320:05EDGAR2Form 8-K - Current report
04/10/202320:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
26/09/202306:07EDGAR2Form 8-K - Current report
21/09/202300:21EDGAR2Form 144 - Report of proposed sale of securities
21/09/202300:15EDGAR2Form 144 - Report of proposed sale of securities
19/09/202321:00EDGAR2Form 8-K - Current report
19/09/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/09/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/09/202305:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock